Business Analysis 12 February 2026

Business Analysis·Finance·NASDAQ:OGI·News·Stock Market·TSX:OGI

Organigram Stock Bounces Off Lows; Margins in Focus Next

Organigram’s Nasdaq shares closed Friday at $1.12, down 0.9% but up 4.7% from May 15, while its TSX shares ended at C$1.56. The company reported a C$0.9 million net loss for the quarter, with revenue down 9% to C$59.8 million. U.S. and Canadian exchanges are split by holidays, with Nasdaq closed Monday for Memorial Day. Organigram raised its 2026 revenue forecast above C$350 million after acquiring Sanity Group.

May 24, 2026

Business Analysis·News·Stock Market·Technology

Cisco stock price drops nearly 8% in premarket after margin miss — what’s next for CSCO

Cisco shares fell 7.9% to $78.74 in premarket trading after quarterly results showed gross margin dropped to 67.5%, missing estimates due to higher memory costs. The company raised its full-year revenue outlook and reported $2.1 billion in AI infrastructure orders, but analysts flagged margin pressure and product mix concerns.

February 12, 2026

ASX Mid-Cap Shares Poised for Growth as Market Shifts from Mega-Caps: VanEck Report
May 29, 2026, 9:14 PM EDT. A VanEck report highlights that ASX mid-cap shares, historically overshadowed by large caps like BHP and Commonwealth Bank, are gaining investor interest. With bond yields at multi-decade highs and large-cap earnings under pressure, mid-caps trading at discounts to the ASX 50 now attract attention for potential earnings growth. VanEck notes that during periods of higher interest rates and slower growth, broader market leadership emerges as investors seek reliable earnings growth beyond mega-caps. Signs of this shift appear in both the U.S. and Australia, where smaller companies have delivered strong earnings surprises post-February reporting. Mid-caps' cheaper valuations amid improving earnings outlooks suggest these stocks may play a bigger role amid inflation, rising bond yields, and geopolitical risks.